CIBC Private Wealth Group
GHDX

CIBC Private Wealth Group’s Genomic Health, Inc. GHDX Stock Holding History

CIBC Private Wealth Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,425
Closed -$451K – 989
2018
Q3 		$451K Buy
6,425
+6,025
+1,506% +$352K ﹤0.01% 801
2018
Q2 		$20K Buy
+400
New +$15.9K ﹤0.01% 1407

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIBC Private Wealth Group's GHDX Position: Q4 2018 in Review

CIBC Private Wealth Group sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 6,425 shares — an estimated $451K sold.

CIBC Private Wealth Group first reported a position in GHDX in Q2 2018 and held it in 2 quarters. The position peaked at $451K in Q3 2018. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • CIBC Private Wealth Group reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 6,425 Genomic Health, Inc. shares in Q4 2018, an estimated $451K.
  • CIBC Private Wealth Group first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 2 quarters.
  • CIBC Private Wealth Group's Genomic Health, Inc. position peaked at $451K in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on CIBC Private Wealth Group's 13F filing for Q4 2018, filed 5 Feb 2019.